<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:ynews="http://news.yahoo.com/rss/">
    <channel>
        <title>Nova Reader - Subject</title>
        <link>https://www.novareader.co</link>
        <description>Default RSS Feed</description>
        <language>en-us</language>
        <copyright>Newgen KnowledgeWorks</copyright>
        <item>
            <title><![CDATA[Brd4-bound enhancers drive cell-intrinsic sex differences in glioblastoma]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766072945232-7b2888ab-aded-40cd-bc59-f0c6fb7cd00f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1073/pnas.2017148118</link>
            <description><![CDATA[<p class="para" id="N65542">Consistent sex differences in incidence and outcome have been reported in numerous cancers including brain tumors. GBM, the most common and aggressive primary brain tumor, occurs with higher incidence and shorter survival in males compared to females. Brd4 is essential for regulating transcriptome-wide gene expression and specifying cell identity, including that of GBM. We report that sex-biased Brd4 activity drives sex differences in GBM and renders male and female tumor cells differentially sensitive to BET inhibitors. The observed sex differences in BETi treatment strongly indicate that sex differences in disease biology translate into sex differences in therapeutic responses. This has critical implications for clinical use of BET inhibitors further affirming the importance of inclusion of sex as a biological variable.</p><p class="para" id="N65539">Sex can be an important determinant of cancer phenotype, and exploring sex-biased tumor biology holds promise for identifying novel therapeutic targets and new approaches to cancer treatment. In an established isogenic murine model of glioblastoma (GBM), we discovered correlated transcriptome-wide sex differences in gene expression, H3K27ac marks, large Brd4-bound enhancer usage, and Brd4 localization to Myc and p53 genomic binding sites. These sex-biased gene expression patterns were also evident in human glioblastoma stem cells (GSCs). These observations led us to hypothesize that Brd4-bound enhancers might underlie sex differences in stem cell function and tumorigenicity in GBM. We found that male and female GBM cells exhibited sex-specific responses to pharmacological or genetic inhibition of Brd4. Brd4 knockdown or pharmacologic inhibition decreased male GBM cell clonogenicity and in vivo tumorigenesis while increasing both in female GBM cells. These results were validated in male and female patient-derived GBM cell lines. Furthermore, analysis of the Cancer Therapeutic Response Portal of human GBM samples segregated by sex revealed that male GBM cells are significantly more sensitive to BET (bromodomain and extraterminal) inhibitors than are female cells. Thus, Brd4 activity is revealed to drive sex differences in stem cell and tumorigenic phenotypes, which can be abrogated by sex-specific responses to BET inhibition. This has important implications for the clinical evaluation and use of BET inhibitors.</p>]]></description>
            <pubDate><![CDATA[2021-04-13T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[BABEL enables cross-modality translation between multiomic profiles at single-cell resolution]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766061264926-3763a604-79ac-4ee6-b6df-0c90220e970c/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1073/pnas.2023070118</link>
            <description><![CDATA[<p class="para" id="N65542">Simultaneous measurement of the DNA, RNA, and proteins of single cells can lead to important new insights but is experimentally challenging. This work introduces a deep learning algorithm that flexibly translates between chromatin, RNA, and protein profiles in single cells. This makes it possible to computationally synthesize matched multiomic measurements when only one modality is experimentally available. This algorithm complements experimental advances to efficiently achieve single-cell multiomic insight.</p><p class="para" id="N65539">Simultaneous profiling of multiomic modalities within a single cell is a grand challenge for single-cell biology. While there have been impressive technical innovations demonstrating feasibility—for example, generating paired measurements of single-cell transcriptome (single-cell RNA sequencing [scRNA-seq]) and chromatin accessibility (single-cell assay for transposase-accessible chromatin using sequencing [scATAC-seq])—widespread application of joint profiling is challenging due to its experimental complexity, noise, and cost. Here, we introduce BABEL, a deep learning method that translates between the transcriptome and chromatin profiles of a single cell. Leveraging an interoperable neural network model, BABEL can predict single-cell expression directly from a cell’s scATAC-seq and vice versa after training on relevant data. This makes it possible to computationally synthesize paired multiomic measurements when only one modality is experimentally available. Across several paired single-cell ATAC and gene expression datasets in human and mouse, we validate that BABEL accurately translates between these modalities for individual cells. BABEL also generalizes well to cell types within new biological contexts not seen during training. Starting from scATAC-seq of patient-derived basal cell carcinoma (BCC), BABEL generated single-cell expression that enabled fine-grained classification of complex cell states, despite having never seen BCC data. These predictions are comparable to analyses of experimental BCC scRNA-seq data for diverse cell types related to BABEL’s training data. We further show that BABEL can incorporate additional single-cell data modalities, such as protein epitope profiling, thus enabling translation across chromatin, RNA, and protein. BABEL offers a powerful approach for data exploration and hypothesis generation.</p>]]></description>
            <pubDate><![CDATA[2021-04-07T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Establishment of heterochromatin in domain-size-dependent bursts]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766061093935-e7c4ddae-6761-4413-b13a-b1417c3c4eba/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1073/pnas.2022887118</link>
            <description><![CDATA[<p class="para" id="N65542">How repressive heterochromatic states propagate along chromosomes and are subsequently maintained for many cell divisions remain important unanswered questions in biology. Combining mathematical modeling and single-cell measurements, we find that heterochromatin does not propagate in a purely linear manner as often assumed. Rather, sudden transitions can affect large domains globally at once. We suggest this is due to long-range interactions that bring distant nucleosomes close to each other to facilitate their modification. This supports the notion that the compartmentalization of chromatin components within the nucleus and the folding of chromatin into loops dynamically control heterochromatin propagation in three dimensions by bringing nucleosomes and their modifiers into close proximity.</p><p class="para" id="N65539">Methylation of histone H3K9 is a hallmark of epigenetic silencing in eukaryotes. Nucleosome modifications often rely on positive feedback where enzymes are recruited by modified nucleosomes. A combination of local and global feedbacks has been proposed to account for some dynamic properties of heterochromatin, but the range at which the global feedbacks operate and the exact mode of heterochromatin propagation are not known. We investigated these questions in fission yeast. Guided by mathematical modeling, we incrementally increased the size of the mating-type region and profiled heterochromatin establishment over time. We observed exponential decays in the proportion of cells with active reporters, with rates that decreased with domain size. Establishment periods varied from a few generations in wild type to &gt;200 generations in the longest region examined, and highly correlated silencing of two reporters located outside the nucleation center was observed. On a chromatin level, this indicates that individual regions are silenced in sudden bursts. Mathematical modeling accounts for these bursts if heterochromatic nucleosomes facilitate a deacetylation or methylation reaction at long range, in a distance-independent manner. A likely effector of three-dimensional interactions is the evolutionarily conserved Swi6<sup>HP1</sup> H3K9me reader, indicating the bursting behavior might be a general mode of heterochromatin propagation.</p>]]></description>
            <pubDate><![CDATA[2021-04-07T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A model and test for coordinated polygenic epistasis in complex traits]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766060325385-9a1fa67c-e1fc-4a85-a8de-35322a7d6c31/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1073/pnas.1922305118</link>
            <description><![CDATA[<p class="para" id="N65542">Systems-level interactions across physiological pathways, cell types, and tissues are core biological elements widely studied across diverse fields including evolution, systems biology, and model-organism genetics. However, they are essentially ignored in human genetics, and existing approaches fail to interpretably explain substantial complex trait heritability. Here, we propose the coordinated epistasis model of complex phenotypes that generalizes several recently proposed theoretical epistatic architectures of human traits. Broadly, coordination measures the degree to which epistasis effects act in concert with respect to marginal effects. It summarizes a dimension of polygenic effects orthogonal to parameters like heritability and standard estimates of epistasis.</p><p class="para" id="N65539">Interactions between genetic variants—epistasis—is pervasive in model systems and can profoundly impact evolutionary adaption, population disease dynamics, genetic mapping, and precision medicine efforts. In this work, we develop a model for structured polygenic epistasis, called coordinated epistasis (CE), and prove that several recent theories of genetic architecture fall under the formal umbrella of CE. Unlike standard epistasis models that assume epistasis and main effects are independent, CE captures systematic correlations between epistasis and main effects that result from pathway-level epistasis, on balance skewing the penetrance of genetic effects. To test for the existence of CE, we propose the even-odd (EO) test and prove it is calibrated in a range of realistic biological models. Applying the EO test in the UK Biobank, we find evidence of CE in 18 of 26 traits spanning disease, anthropometric, and blood categories. Finally, we extend the EO test to tissue-specific enrichment and identify several plausible tissue–trait pairs. Overall, CE is a dimension of genetic architecture that can capture structured, systemic forms of epistasis in complex human traits.</p>]]></description>
            <pubDate><![CDATA[2021-04-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Identification of a micropeptide and multiple secondary cell genes that modulate <i>Drosophila</i> male reproductive success]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766060075148-325af9e8-ec0a-48db-8c6c-701cd39542f7/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1073/pnas.2001897118</link>
            <description><![CDATA[<p class="para" id="N65542">In many species, mating induces physiological changes in the female that increase the reproductive success of the mating pair. The postmating response (PMR) is caused by male seminal fluid proteins interacting with the female reproductive system. Because of the importance of the PMR in many insect species relevant to human health and agriculture, we examined the gene expression profile of one important cell type of the gland that produces most of the seminal fluid proteins in <i>Drosophila.</i> Interestingly, among proteins necessary for the PMR in this species, we discovered that a micropeptide encoded by a supposedly noncoding transcript is produced and carries out important reproductive functions. Such micropeptides were previously unrecognized but are emerging as important actors in complex biological processes.</p><p class="para" id="N65539">Even in well-characterized genomes, many transcripts are considered noncoding RNAs (ncRNAs) simply due to the absence of large open reading frames (ORFs). However, it is now becoming clear that many small ORFs (smORFs) produce peptides with important biological functions. In the process of characterizing the ribosome-bound transcriptome of an important cell type of the seminal fluid-producing accessory gland of <i>Drosophila melanogaster</i>, we detected an RNA, previously thought to be noncoding, called <i>male-specific abdominal</i> (<i>msa</i>). Notably, <i>msa</i> is nested in the HOX gene cluster of the Bithorax complex and is known to contain a micro-RNA within one of its introns. We find that this RNA encodes a “micropeptide” (9 or 20 amino acids, MSAmiP) that is expressed exclusively in the secondary cells of the male accessory gland, where it seems to accumulate in nuclei. Importantly, loss of function of this micropeptide causes defects in sperm competition. In addition to bringing insights into the biology of a rare cell type, this work underlines the importance of small peptides, a class of molecules that is now emerging as important actors in complex biological processes.</p>]]></description>
            <pubDate><![CDATA[2021-04-05T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[ZYP1 is required for obligate cross-over formation and cross-over interference in <i>Arabidopsis</i>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766030871021-38b90d44-bf8f-43f4-9b90-e532f0fce042/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1073/pnas.2021671118</link>
            <description><![CDATA[<p class="para" id="N65542">The synaptonemal complex (SC) is a meiosis-specific proteinaceous ultrastructure required to ensure cross-over (CO) formation in the majority of sexually reproducing eukaryotes. It is composed of two lateral elements adjoined by transverse filaments. Even though the general structure of the SC is conserved throughout kingdoms, phenotypic differences between mutants perpetuate the enigmatic role of the SC. Here, we have used genetic and cytogenetic approaches to show that the transverse filament protein, ZYP1, acts on multiple pathways of meiotic recombination in <i>Arabidopsis</i>. ZYP1 is required for CO assurance, thus ensuring that every chromosome pair receives at least one CO. ZYP1 limits the number of COs and mediates CO interference, the phenomenon that reduces the probability of multiple COs forming close together.</p><p class="para" id="N65539">The synaptonemal complex is a tripartite proteinaceous ultrastructure that forms between homologous chromosomes during prophase I of meiosis in the majority of eukaryotes. It is characterized by the coordinated installation of transverse filament proteins between two lateral elements and is required for wild-type levels of crossing over and meiotic progression. We have generated null mutants of the duplicated <i>Arabidopsis</i> transverse filament genes <i>zyp1a</i> and <i>zyp1b</i> using a combination of T-DNA insertional mutants and targeted CRISPR/Cas mutagenesis. Cytological and genetic analysis of the <i>zyp1</i> null mutants reveals loss of the obligate chiasma, an increase in recombination map length by 1.3- to 1.7-fold and a virtual absence of cross-over (CO) interference, determined by a significant increase in the number of double COs. At diplotene, the numbers of HEI10 foci, a marker for Class I interference-sensitive COs, are twofold greater in the <i>zyp1</i> mutant compared to wild type. The increase in recombination in <i>zyp1</i> does not appear to be due to the Class II interference-insensitive COs as chiasmata were reduced by ∼52% in <i>msh5/zyp1</i> compared to <i>msh5</i>. These data suggest that ZYP1 limits the formation of closely spaced Class I COs in <i>Arabidopsis</i>. Our data indicate that installation of ZYP1 occurs at ASY1-labeled axial bridges and that loss of the protein disrupts progressive coalignment of the chromosome axes.</p>]]></description>
            <pubDate><![CDATA[2021-03-29T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Perfect Match Genomic Landscape strategy: Refinement and customization of reference genomes]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766030817825-16a74b65-8957-4237-ad64-f007eded512f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1073/pnas.2025192118</link>
            <description><![CDATA[<p class="para" id="N65542">The accuracy of the nucleotide sequence of genomes is of utmost importance. The Perfect Match Genomic Landscape (PMGL) is a precise, sensitive, and nonstatistical strategy to detect genome variation. We used this strategy to refine reference genomes from microorganisms belonging to the three domains of life. Our studies show as well that the PMGL can be useful to detect variants in pathogen agents during a pandemic, and to isolate mutations generated during any desired stage of experimental evolution studies. We propose that the PMGL strategy could be the final step in the refinement of any haploid genome, independently of the methodology and algorithms used for its assembly.</p><p class="para" id="N65539">When addressing a genomic question, having a reliable and adequate reference genome is of utmost importance. This drives the necessity to refine and customize reference genomes (RGs). Our laboratory has recently developed a strategy, the Perfect Match Genomic Landscape (PMGL), to detect variation between genomes [K. Palacios-Flores <i>et al.</i>. <i>Genetics</i> 208, 1631–1641 (2018)]. The PMGL is precise and sensitive and, in contrast to most currently used algorithms, is nonstatistical in nature. Here we demonstrate the power of PMGL to refine and customize RGs. As a proof-of-concept, we refined different versions of the <i>Saccharomyces cerevisiae</i> RG. We applied the automatic PMGL pipeline to refine the genomes of microorganisms belonging to the three domains of life: the archaea <i>Methanococcus maripaludis</i> and <i>Pyrococcus furiosus</i>; the bacteria <i>Escherichia coli</i>, <i>Staphylococcus aureus</i>, and <i>Bacillus subtilis</i>; and the eukarya <i>Schizosaccharomyces pombe</i>, <i>Aspergillus oryzae</i>, and several strains of <i>Saccharomyces paradoxus.</i> We analyzed the reference genome of the virus SARS-CoV-2 and previously published viral genomes from patients’ samples with COVID-19. We performed a mutation-accumulation experiment in <i>E. coli</i> and show that the PMGL strategy can detect specific mutations generated at any desired step of the whole procedure. We propose that PMGL can be used as a final step for the refinement and customization of any haploid genome, independently of the strategies and algorithms used in its assembly.</p>]]></description>
            <pubDate><![CDATA[2021-03-18T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Use of NAD tagSeq II to identify growth phase-dependent alterations in <i>E. coli</i> RNA NAD<sup>+</sup> capping]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766030638344-9672fa34-6d1e-4fe3-8701-e9a303818479/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1073/pnas.2026183118</link>
            <description><![CDATA[<p class="para" id="N65542">Some RNAs in both prokaryotes and eukaryotes were recently found to contain the NAD<sup>+</sup> cap, indicating a novel mechanism in gene regulation through noncanonical RNA capping. Copper-catalyzed azide-alkyne cycloaddition (CuAAC) click chemistry has been used to label NAD<sup>+</sup>-capped RNAs (NAD-RNAs) for their identification. However, copper-caused RNA fragmentation/degradation interferes with the analysis. We developed the NAD tagSeq II method for transcriptome-wide NAD-RNA analysis based on copper-free, strain-promoted azide-alkyne cycloaddition (SPAAC) click chemistry. This method was used to compare NAD-RNA and total transcriptome profiles in <i>Escherichia coli</i>. Our study reveals genome-wide alterations in <i>E. coli</i> RNA NAD<sup>+</sup> capping in different growth phases and indicates that NAD-RNAs could be the primary form of transcripts from some genes under certain environments.</p><p class="para" id="N65539">Recent findings regarding nicotinamide adenine dinucleotide (NAD<sup>+</sup>)-capped RNAs (NAD-RNAs) indicate that prokaryotes and eukaryotes employ noncanonical RNA capping to regulate gene expression. Two methods for transcriptome-wide analysis of NAD-RNAs, NAD captureSeq and NAD tagSeq, are based on copper-catalyzed azide-alkyne cycloaddition (CuAAC) click chemistry to label NAD-RNAs. However, copper ions can fragment/degrade RNA, interfering with the analyses. Here we report development of NAD tagSeq II, which uses copper-free, strain-promoted azide-alkyne cycloaddition (SPAAC) for labeling NAD-RNAs, followed by identification of tagged RNA by single-molecule direct RNA sequencing. We used this method to compare NAD-RNA and total transcript profiles of <i>Escherichia coli</i> cells in the exponential and stationary phases. We identified hundreds of NAD-RNA species in <i>E. coli</i> and revealed genome-wide alterations of NAD-RNA profiles in the different growth phases. Although no or few NAD-RNAs were detected from some of the most highly expressed genes, the transcripts of some genes were found to be primarily NAD-RNAs. Our study suggests that NAD-RNAs play roles in linking nutrient cues with gene regulation in <i>E. coli</i>.</p>]]></description>
            <pubDate><![CDATA[2021-03-29T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Cancer-specific loss of <i>TERT</i> activation sensitizes glioblastoma to DNA damage]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766004802246-9dedf05a-9b74-4713-a1af-d03d19946176/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1073/pnas.2008772118</link>
            <description><![CDATA[<p class="para" id="N65542">Glioblastoma is a highly lethal form of brain cancer with no current treatment options that substantially improve patient outcomes. A key therapeutic challenge is the identification of methods that reduce tumor burden while leaving normal cells unaffected. We show that <i>TERT</i>-promoter mutations, common in glioblastoma, lead to <i>TERT</i> reactivation through increased binding of GABPB1L-isoform–containing transcription factor complexes. In turn, we find that cancer-cell–specific inhibition of <i>TERT</i> through GABPB1L reduction results in near-term anti-growth effects and an impaired DNA damage response that profoundly increase the sensitivity of glioblastoma tumors to frontline chemotherapy. Our results thus provide rationale for GABPB1L inhibition combined with temozolomide chemotherapy treatment as a promising therapeutic strategy for glioblastoma.</p><p class="para" id="N65539">Most glioblastomas (GBMs) achieve cellular immortality by acquiring a mutation in the telomerase reverse transcriptase (<i>TERT</i>) promoter. <i>TERT</i> promoter mutations create a binding site for a GA binding protein (GABP) transcription factor complex, whose assembly at the promoter is associated with <i>TERT</i> reactivation and telomere maintenance. Here, we demonstrate increased binding of a specific GABPB1L-isoform–containing complex to the mutant <i>TERT</i> promoter. Furthermore, we find that <i>TERT</i> promoter mutant GBM cells, unlike wild-type cells, exhibit a critical near-term dependence on GABPB1L for proliferation, notably also posttumor establishment in vivo. Up-regulation of the protein paralogue GABPB2, which is normally expressed at very low levels, can rescue this dependence. More importantly, when combined with frontline temozolomide (TMZ) chemotherapy, inducible GABPB1L knockdown and the associated <i>TERT</i> reduction led to an impaired DNA damage response that resulted in profoundly reduced growth of intracranial GBM tumors. Together, these findings provide insights into the mechanism of cancer-specific <i>TERT</i> regulation, uncover rapid effects of GABPB1L-mediated <i>TERT</i> suppression in GBM maintenance, and establish GABPB1L inhibition in combination with chemotherapy as a therapeutic strategy for <i>TERT</i> promoter mutant GBM.</p>]]></description>
            <pubDate><![CDATA[2021-03-23T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A genomic region associated with protection against severe COVID-19 is inherited from Neandertals]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765992265593-56710bc1-6750-4945-a0bc-a8a276958cc3/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1073/pnas.2026309118</link>
            <description><![CDATA[<p class="para" id="N65542">We show that a haplotype on chromosome 12, which is associated with a ∼22% reduction in relative risk of becoming severely ill with COVID-19 when infected by SARS-CoV-2, is inherited from Neandertals. This haplotype is present at substantial frequencies in all regions of the world outside Africa. The genomic region where this haplotype occurs encodes proteins that are important during infections with RNA viruses.</p><p class="para" id="N65539">It was recently shown that the major genetic risk factor associated with becoming severely ill with COVID-19 when infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is inherited from Neandertals. New, larger genetic association studies now allow additional genetic risk factors to be discovered. Using data from the Genetics of Mortality in Critical Care (GenOMICC) consortium, we show that a haplotype at a region on chromosome 12 associated with requiring intensive care when infected with the virus is inherited from Neandertals. This region encodes proteins that activate enzymes that are important during infections with RNA viruses. In contrast to the previously described Neandertal haplotype that increases the risk for severe COVID-19, this Neandertal haplotype is protective against severe disease. It also differs from the risk haplotype in that it has a more moderate effect and occurs at substantial frequencies in all regions of the world outside Africa. Among ancient human genomes in western Eurasia, the frequency of the protective Neandertal haplotype may have increased between 20,000 and 10,000 y ago and again during the past 1,000 y.</p>]]></description>
            <pubDate><![CDATA[2021-02-15T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Mitochondrial hydrogen sulfide supplementation improves health in the <i>C. elegans</i> Duchenne muscular dystrophy model]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765991809017-4354f3c7-17ae-4e98-8136-dfde0f8ad3e3/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1073/pnas.2018342118</link>
            <description><![CDATA[<p class="para" id="N65542">Duchenne muscular dystrophy (DMD) is a fatal degenerative disease without a cure. Current standard pharmacological treatment is corticosteroids. Their prolonged use is associated with several undesirable side effects. Using <i>Caenorhabditis elegans</i>, we have identified pharmacological treatments that supplement hydrogen sulfide (H<sub>2</sub>S). One, sodium GYY4137, largely acts like prednisone to improve neuromuscular health; the other, AP39, targets H<sub>2</sub>S delivery to mitochondria. As these are not steroids, they are unlikely to produce steroid-induced side effects. Additionally, as DMD mice show a decline in total sulfide, our results pave the way for evaluation of cellular and/or mitochondrial H<sub>2</sub>S in DMD pathology and warrant further investigation of selective H<sub>2</sub>S delivery approaches in <i>mdx</i> mice and/or higher animal models of DMD.</p><p class="para" id="N65539">Duchenne muscular dystrophy (DMD) is an X-linked recessive disorder characterized by progressive muscle degeneration and weakness due to mutations in the dystrophin gene. The symptoms of DMD share similarities with those of accelerated aging. Recently, hydrogen sulfide (H<sub>2</sub>S) supplementation has been suggested to modulate the effects of age-related decline in muscle function, and metabolic H<sub>2</sub>S deficiencies have been implicated in affecting muscle mass in conditions such as phenylketonuria. We therefore evaluated the use of sodium GYY4137 (NaGYY), a H<sub>2</sub>S-releasing molecule, as a possible approach for DMD treatment. Using the <i>dys-1(eg</i>33<i>) Caenorhabditis elegans</i> DMD model, we found that NaGYY treatment (100 µM) improved movement, strength, gait, and muscle mitochondrial structure, similar to the gold-standard therapeutic treatment, prednisone (370 µM). The health improvements of either treatment required the action of the kinase JNK-1, the transcription factor SKN-1, and the NAD-dependent deacetylase SIR-2.1. The transcription factor DAF-16 was required for the health benefits of NaGYY treatment, but not prednisone treatment. AP39 (100 pM), a mitochondria-targeted H<sub>2</sub>S compound, also improved movement and strength in the <i>dys-1(eg</i>33<i>)</i> model, further implying that these improvements are mitochondria-based. Additionally, we found a decline in total sulfide and H<sub>2</sub>S-producing enzymes in dystrophin/utrophin knockout mice. Overall, our results suggest that H<sub>2</sub>S deficit may contribute to DMD pathology, and rectifying/overcoming the deficit with H<sub>2</sub>S delivery compounds has potential as a therapeutic approach to DMD treatment.</p>]]></description>
            <pubDate><![CDATA[2021-02-24T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Cell type-specific modulation of healthspan by Forkhead family transcription factors in the nervous system]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765980704682-ca76fd8e-4e2a-4b6a-8119-9b1d02eb8d39/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1073/pnas.2011491118</link>
            <description><![CDATA[<p class="para" id="N65542">Aging is the main risk factor for the costliest diseases in today’s world. However, significant gaps remain in understanding how different cell types modulate this most common physiological process. Here, we use published single-cell gene expression data to map the prolongevity roles of two evolutionarily conserved <i>Drosophila</i> transcription factors, FKH and FOXO, onto either neuronal or glial cells. We then demonstrate that neuronal FKH preserves healthy function even under stress. Finally, we identify an autophagy-related gene as one of FKH’s downstream prolongevity effectors. Our results exemplify tapping into publicly available gene expression datasets to extract physiological insights, and highlight the need to shift away from organism-wide approaches and toward cell type-specific strategies to obtain meaningful insights in aging research.</p><p class="para" id="N65539">Reduced activity of insulin/insulin-like growth factor signaling (IIS) increases healthy lifespan among diverse animal species. Downstream of IIS, multiple evolutionarily conserved transcription factors (TFs) are required; however, distinct TFs are likely responsible for these effects in different tissues. Here we have asked which TFs can extend healthy lifespan within distinct cell types of the adult nervous system in <i>Drosophila</i>. Starting from published single-cell transcriptomic data, we report that <i>forkhead</i> (FKH) is endogenously expressed in neurons, whereas <i>forkhead-box-O</i> (FOXO) is expressed in glial cells. Accordingly, we find that neuronal FKH and glial FOXO exert independent prolongevity effects. We have further explored the role of neuronal FKH in a model of Alzheimer’s disease-associated neuronal dysfunction, where we find that increased neuronal FKH preserves behavioral function and reduces ubiquitinated protein aggregation. Finally, using transcriptomic profiling, we identify <i>Atg17</i>, a member of the Atg1 autophagy initiation family, as one FKH-dependent target whose neuronal overexpression is sufficient to extend healthy lifespan. Taken together, our results underscore the importance of cell type-specific mapping of TF activity to preserve healthy function with age.</p>]]></description>
            <pubDate><![CDATA[2021-02-15T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Accurate SNV detection in single cells by transposon-based whole-genome amplification of complementary strands]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765980695336-f1ef85eb-96a6-4321-ac00-9bc1d5eab42d/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1073/pnas.2013106118</link>
            <description><![CDATA[<p class="para" id="N65542">The boom of single-cell sequencing technologies in the past decade has profoundly expanded our understanding of fundamental biology. Today, tens of thousands of cells can be measured by single-cell RNA-seq in one experiment. However, single-cell DNA-sequencing studies have been limited by false positives and cost. Here we report META-CS, a single-cell whole-genome amplification method that takes advantage of the complementary strands of double-stranded DNA to filter out false positives and reduce sequencing cost. META-CS achieved the highest accuracy in terms of detecting single-nucleotide variations, and provided potential solutions for the identification of other genomic variants, such as insertions, deletions, and structural variations in single cells.</p><p class="para" id="N65539">Single-nucleotide variants (SNVs), pertinent to aging and disease, occur sporadically in the human genome, hence necessitating single-cell measurements. However, detection of single-cell SNVs suffers from false positives (FPs) due to intracellular single-stranded DNA damage and the process of whole-genome amplification (WGA). Here, we report a single-cell WGA method termed multiplexed end-tagging amplification of complementary strands (META-CS), which eliminates nearly all FPs by virtue of DNA complementarity, and achieved the highest accuracy thus far. We validated META-CS by sequencing kindred cells and human sperm, and applied it to other human tissues. Investigation of mature single human neurons revealed increasing SNVs with age and potentially unrepaired strand-specific oxidative guanine damage. We determined SNV frequencies along the genome in differentiated single human blood cells, and identified cell type-dependent mutational patterns for major types of lymphocytes.</p>]]></description>
            <pubDate><![CDATA[2021-02-15T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[<i>Trichoderma reesei</i> Rad51 tolerates mismatches in hybrid meiosis with diverse genome sequences]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765980525837-6a649f3e-a180-4843-8946-1edbf0a2e1e7/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1073/pnas.2007192118</link>
            <description><![CDATA[<p class="para" id="N65542">Sexual eukaryotes fall into two groups with respect to their RecA-like recombinases. The first group possesses Rad51 (ubiquitous) and Dmc1 (meiosis-specific), which cooperate to conduct interhomolog recombination in zygotes with high sequence heterogeneity. Interestingly, Dmc1 was lost from the second group of eukaryotic organisms. Here we used the industrial workhorse fungus <i>Trichoderma reesei</i> to address if and how Rad51-only eukaryotes carry out hybrid meiosis. We show that <i>T. reesei</i> Rad51 (<i>Tr</i>Rad51) is indispensable for interhomolog recombination during meiosis and that <i>Tr</i>Rad51, like <i>Saccharomyces cerevisiae</i> Dmc1, possesses a better mismatch tolerability than <i>S. cerevisiae</i> Rad51. Our results indicate that the ancestral <i>Tr</i>Rad51 evolved to acquire Dmc1-like properties by adopting multiple structural variations in the L1 and L2 DNA-binding loops.</p><p class="para" id="N65539">Most eukaryotes possess two RecA-like recombinases (ubiquitous Rad51 and meiosis-specific Dmc1) to promote interhomolog recombination during meiosis. However, some eukaryotes have lost Dmc1. Given that mammalian and yeast <i>Saccharomyces cerevisiae</i> (<i>Sc</i>) Dmc1 have been shown to stabilize recombination intermediates containing mismatches better than Rad51, we used the Pezizomycotina filamentous fungus <i>Trichoderma reesei</i> to address if and how Rad51-only eukaryotes conduct interhomolog recombination in zygotes with high sequence heterogeneity. We applied multidisciplinary approaches (next- and third-generation sequencing technology, genetics, cytology, bioinformatics, biochemistry, and single-molecule biophysics) to show that <i>T. reesei</i> Rad51 (<i>Tr</i>Rad51) is indispensable for interhomolog recombination during meiosis and, like <i>Sc</i>Dmc1, <i>Tr</i>Rad51 possesses better mismatch tolerance than <i>Sc</i>Rad51 during homologous recombination. Our results also indicate that the ancestral <i>Tr</i>Rad51 evolved to acquire <i>Sc</i>Dmc1-like properties by creating multiple structural variations, including via amino acid residues in the L1 and L2 DNA-binding loops.</p>]]></description>
            <pubDate><![CDATA[2021-02-15T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Replication-independent instability of Friedreich’s ataxia GAA repeats during chronological aging]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765863735626-1afaf7d8-4eaa-409e-9a81-019fafbc84e4/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1073/pnas.2013080118</link>
            <description><![CDATA[<p class="para" id="N65542">The inheritance of long (GAA)<sub>n</sub> repeats in the frataxin gene causes the debilitating neurodegenerative disease Friedreich’s ataxia. Subsequent expansions of these repeats throughout a patient’s lifetime in the affected tissues, like the nervous system, may contribute to disease onset. We developed an experimental model to characterize the mechanisms of repeat instability in nondividing cells to better understand how mutations can occur as cells age chronologically. We show that repeats can expand in nondividing cells. Notably, however, large deletions are the major type of repeat-mediated genome instability in nondividing cells, implicating the loss of important genetic material with aging in the progression of Friedreich’s ataxia.</p><p class="para" id="N65539">Nearly 50 hereditary diseases result from the inheritance of abnormally long repetitive DNA microsatellites. While it was originally believed that the size of inherited repeats is the key factor in disease development, it has become clear that somatic instability of these repeats throughout an individual’s lifetime strongly contributes to disease onset and progression. Importantly, somatic instability is commonly observed in terminally differentiated, postmitotic cells, such as neurons. To unravel the mechanisms of repeat instability in nondividing cells, we created an experimental system to analyze the mutability of Friedreich’s ataxia (GAA)<sub>n</sub> repeats during chronological aging of quiescent <i>Saccharomyces cerevisiae</i>. Unexpectedly, we found that the predominant repeat-mediated mutation in nondividing cells is large-scale deletions encompassing parts, or the entirety, of the repeat and adjacent regions. These deletions are caused by breakage at the repeat mediated by mismatch repair (MMR) complexes MutSβ and MutLα and DNA endonuclease Rad1, followed by end-resection by Exo1 and repair of the resulting double-strand breaks (DSBs) via nonhomologous end joining. We also observed repeat-mediated gene conversions as a result of DSB repair via ectopic homologous recombination during chronological aging. Repeat expansions accrue during chronological aging as well—particularly in the absence of MMR-induced DSBs. These expansions depend on the processivity of DNA polymerase δ while being counteracted by Exo1 and MutSβ, implicating nick repair. Altogether, these findings show that the mechanisms and types of (GAA)<sub>n</sub> repeat instability differ dramatically between dividing and nondividing cells, suggesting that distinct repeat-mediated mutations in terminally differentiated somatic cells might influence Friedreich’s ataxia pathogenesis.</p>]]></description>
            <pubDate><![CDATA[2021-01-25T00:00]]></pubDate>
        </item>
    </channel>
</rss>